The pharmaceutical giant's quarterly results also benefited from a smaller-than-feared drop in sales for its Covid antiviral ...
All the more reason to worry that Covid vaccines may have tarnished ... Thrombosis caused by the AstraZeneca vaccine and ...
The nod covers the prevention of lower respiratory tract disease (LRTD) in all newborns, infants and children ... week mark. Pfizer-BioNTech’s and Moderna’s mRNA-based COVID-19 vaccines ...
In 2017, then-newly elected Mayor Mike Purzycki sat on a stage close by to Velda Jones-Potter as she gave her inaugural ...
Pfizer beat first-quarter profit estimates on Wednesday, benefiting from cost cuts and strong sales for its pneumonia and ...
Physicians are unequivocal about who is the big kahuna in the vaccine industry. | Physicians are unequivocal about who is the ...
Pfizer reports Q1 results: adjusted EPS beats estimates, driven by revenue growth. Significant declines in Comirnaty and ...
Pfizer shares rose more than 6% Wednesday afternoon after ... down 20% from a year ago largely because of a drop in its Covid ...
Pfizer Inc. reported financial results for the first quarter of 2024 and raised its Adjusted(3) diluted EPS guidance while maintaining all other components of its 2024 financial guidance(6). The first ...
Cancer vaccines have gained much interest among scientists but face a number of hurdles. A new mRNA vaccine for glioma offers ...
Since the February 26, 2024, announcement at ViVE of the development of the "Smart Hospital Maturity Model," enthusiasm from across the industry has led to broader involvement to guide the initiative.